Engrave Wealth Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-76	Closed	-$9K	–	96
2020 Q2	$9K	Buy	76 +32	+73%	+$3.79K	0.01%	254
2020 Q1	$3K	Sell	44 -74	-63%	-$5.05K	﹤0.01%	308
2019 Q4	$9K	Buy	+118	New	+$9K	0.01%	308